DOI QR코드

DOI QR Code

Low Counts of γδ T Cells in Peritumoral Liver Tissue are Related to More Frequent Recurrence in Patients with Hepatocellular Carcinoma after Curative Resection

  • Cai, Xiao-Yan (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis & Cancer Invasion, The Chinese Ministry of Education) ;
  • Wang, Jia-Xing (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis & Cancer Invasion, The Chinese Ministry of Education) ;
  • Yi, Yong (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis & Cancer Invasion, The Chinese Ministry of Education) ;
  • He, Hong-Wei (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis & Cancer Invasion, The Chinese Ministry of Education) ;
  • Ni, Xiao-Chun (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis & Cancer Invasion, The Chinese Ministry of Education) ;
  • Zhou, Jian (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis & Cancer Invasion, The Chinese Ministry of Education) ;
  • Cheng, Yun-Feng (Biomedical Research Center, Zhongshan Hospital, Fudan University) ;
  • Jin, Jian-Jun (Biomedical Research Center, Zhongshan Hospital, Fudan University) ;
  • Fan, Jia (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis & Cancer Invasion, The Chinese Ministry of Education) ;
  • Qiu, Shuang-Jian (Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis & Cancer Invasion, The Chinese Ministry of Education)
  • Published : 2014.01.30

Abstract

Objectives: TCR-gamma-delta+T cells (${\gamma}{\delta}$ T cells) are non-conventional T lymphocytes that can recognize and eradicate tumor cells. Our previous studies showed that infiltration and function of ${\gamma}{\delta}$ T cells were substantially attenuated in hepatocellular carcinoma (HCC). However, their prognostic value was not clarified. Methods: The association between ${\gamma}{\delta}$ T cells and the clinical outcomes was determined by immunohistochemistry (IHC) in a HCC patient cohort (n = 342). Results:Immunohistochemistry showed decreased infiltration of ${\gamma}{\delta}$ T cells in tumoral tissues compared with paired peritumoral tissues. The counts of ${\gamma}{\delta}$ T cells in peritumoral tissues were negatively correlated with tumor size (P = 0.005). Survival analysis showed that the levels of peritumoral ${\gamma}{\delta}$T cells were related to both time to recurrence (TTR) and overall survival (OS) (P = 0.010 and P = 0.036, respectively) in univariate analysis, and related to TTR in multivariate analysis (P = 0.014, H.R. [95% CI] = 0.682 [0.502-0.927]). Furthermore, the level of peritumoral ${\gamma}{\delta}$ T cells showed independent prognostic value for TTR in Barcelona Clinic Liver Cancer (BCLC) stage A patients (P = 0.038, H.R. [95% CI] = 0.727 [0.537-0.984]). However, tumoral ${\gamma}{\delta}$ T cells did not show independent prognostic value for either TTR or OS in HCC patients. Conclusions: Low counts of ${\gamma}{\delta}$ T cells in peritumoral liver tissue are related to a higher incidence of recurrence in HCC and can predict postoperative recurrence, especially in those with early-stage HCC.

Keywords

References

  1. Bonneville M, O'Brien RL, Born WK (2010) Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol, 10, 467-78. https://doi.org/10.1038/nri2781
  2. Born WK, Reardon CL, O'Brien RL (2006) The function of gammadelta T cells in innate immunity. Curr Opin Immunol, 18, 31-8. https://doi.org/10.1016/j.coi.2005.11.007
  3. Braza MS, Caraux A, Rousset T et al (2010) gammadelta T lymphocytes count is normal and expandable in peripheral blood of patients with follicular lymphoma, whereas it is decreased in tumor lymph nodes compared with inflammatory lymph nodes. J Immunol, 184, 134-40. https://doi.org/10.4049/jimmunol.0901980
  4. Braza MS, Klein B, Fiol G et al (2011) gammadelta T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody. Haematologica, 96, 400-7. https://doi.org/10.3324/haematol.2010.029520
  5. Caccamo N, Meraviglia S, Ferlazzo V et al (2005) Differential requirements for antigen or homeostatic cytokines for proliferation and differentiation of human Vgamma9Vdelta2 naive, memory and effector T cell subsets. Eur J Immunol, 35, 1764-72. https://doi.org/10.1002/eji.200525983
  6. Cai XY, Gao Q, Qiu SJ et al (2006) Dendritic cell infiltration and prognosis of human hepatocellular carcinoma. J Cancer Res Clin Oncol, 132, 293-301. https://doi.org/10.1007/s00432-006-0075-y
  7. Dunn GP, Bruce AT, Ikeda H et al (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol, 3, 991-8. https://doi.org/10.1038/ni1102-991
  8. El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132, 2557-76. https://doi.org/10.1053/j.gastro.2007.04.061
  9. Galon J, Costes A, Sanchez-Cabo F et al (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science, 313, 1960-4. https://doi.org/10.1126/science.1129139
  10. Gao B, Jeong WI, Tian Z (2008) Liver: An organ with predominant innate immunity. Hepatology, 47, 729-36.
  11. Gao Q, Qiu SJ, Fan J et al (2007) Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol, 25, 2586-93. https://doi.org/10.1200/JCO.2006.09.4565
  12. Gao Q, Wang XY, Qiu SJ et al (2009) Overexpression of PDL1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma. Clin Cancer Res, 15, 971-9. https://doi.org/10.1158/1078-0432.CCR-08-1608
  13. Gao Q, Zhou J, Wang XY et al (2012) Infiltrating memory/senescent T cell ratio predicts extrahepatic metastasis of hepatocellular carcinoma. Ann Surg Oncol, 19, 455-66.
  14. Guo L, Kuroda N, Toi M et al (2001) Increased expression of platelet-derived endothelial cell growth factor in human hepatocellular carcinomas correlated with high Edmondson grades and portal vein tumor thrombosis. Oncol Rep, 8, 871-6.
  15. Ikai I, Arii S, Kojiro M et al (2004) Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer, 101, 796-802. https://doi.org/10.1002/cncr.20426
  16. Ikeda H, Old LJ, Schreiber RD (2002) The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev, 13, 95-109. https://doi.org/10.1016/S1359-6101(01)00038-7
  17. Inman BA, Frigola X, Harris KJ et al (2008) Questionable relevance of gamma delta T lymphocytes in renal cell carcinoma. J Immunol, 180, 3578-84. https://doi.org/10.4049/jimmunol.180.5.3578
  18. Ju MJ, Qiu SJ, Gao Q et al (2009) Combination of peritumoral mast cells and T-regulatory cells predicts prognosis of hepatocellular carcinoma. Cancer Sci, 100, 1267-74. https://doi.org/10.1111/j.1349-7006.2009.01182.x
  19. Kew MC (2012) Hepatocellular carcinoma in developing countries: Prevention, diagnosis and treatment. World J Hepatol, 4, 99-104. https://doi.org/10.4254/wjh.v4.i3.99
  20. Kowalczyk D, Skorupski W, Kwias Z et al (1996) Activated gamma/delta T lymphocytes infiltrating renal cell carcinoma. Immunol Lett, 53, 15-8. https://doi.org/10.1016/0165-2478(96)02605-3
  21. Kuang DM, Peng C, Zhao Q et al (2010) Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells. Hepatology, 51, 154-64. https://doi.org/10.1002/hep.23291
  22. Kuang DM, Zhao Q, Peng C et al (2009) Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J Exp Med, 206, 1327-37. https://doi.org/10.1084/jem.20082173
  23. Li YW, Qiu SJ, Fan J et al (2011) Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection. J Hepatol, 54, 497-505. https://doi.org/10.1016/j.jhep.2010.07.044
  24. Liao R, Wu H, Yi Y et al (2013) Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma. J Exp Clin Cancer Res, 32, 22. https://doi.org/10.1186/1756-9966-32-22
  25. Llovet JM, Di Bisceglie AM, Bruix J et al (2008) Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst, 100, 698-711. https://doi.org/10.1093/jnci/djn134
  26. Norris S, Collins C, Doherty DG et al (1998) Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J Hepatol, 28, 84-90.
  27. Wu H, Chen P, Liao R et al (2012) Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection. J Gastroenterol Hepatol, 27, 1312-9. https://doi.org/10.1111/j.1440-1746.2012.07130.x
  28. Wu X, Zhang JY, Huang A et al (2013) Decreased Vdelta2 gammadelta T cells associated with liver damage by regulation of Th17 response in patients with chronic hepatitis B. J Infect Dis, 208, 1294-304. https://doi.org/10.1093/infdis/jit312
  29. Yi Y, He HW, Wang JX et al (2013a) The functional impairment of HCC-infiltrating gammadelta T cells, partially mediated by regulatory T cells in a TGFbeta- and IL-10-dependent manner. J Hepatol, 58, 977-83. https://doi.org/10.1016/j.jhep.2012.12.015
  30. Yi Y, Wu H, Gao Q et al (2013b) Interferon regulatory factor (IRF)-1 and IRF-2 are associated with prognosis and tumor invasion in HCC. Ann Surg Oncol, 20, 267-76. https://doi.org/10.1245/s10434-012-2487-z
  31. Zhou H, Huang H, Shi J et al (2010) Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resection. Gut, 59, 1699-708. https://doi.org/10.1136/gut.2010.218404

Cited by

  1. Clinical Significance of Joint Detection of Serum VEGF, SIL-2R and HGF in Patients with Primary Hepatocellular Carcinoma before and after Percutaneous Microwave Coagulation Therapy vol.15, pp.11, 2014, https://doi.org/10.7314/APJCP.2014.15.11.4545
  2. Elevated PIVKA-II is Associated with Early Recurrence and Poor Prognosis in BCLC 0-A Hepatocellular Carcinomas vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6673
  3. Liver-infiltrating CD11b−CD27− NK subsets account for NK-cell dysfunction in patients with hepatocellular carcinoma and are associated with tumor progression vol.14, pp.10, 2017, https://doi.org/10.1038/cmi.2016.28
  4. Tumor-infiltrating γδT cells predict prognosis and adjuvant chemotherapeutic benefit in patients with gastric cancer vol.6, pp.11, 2017, https://doi.org/10.1080/2162402X.2017.1353858
  5. γδ T cells in liver diseases vol.12, pp.3, 2018, https://doi.org/10.1007/s11684-017-0584-x